Mirae Asset Global Etfs Holdings Ltd. Vera Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 21,317 shares of VERA stock, worth $720,940. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,317
Previous 25,735
17.17%
Holding current value
$720,940
Previous $931,000
1.07%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
185Shares Held
55.6MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$146 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$133 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$113 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$100 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$94.5 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $915M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...